Filing Details

Accession Number:
0001562180-23-003795
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-02 14:04:41
Reporting Period:
2023-05-01
Accepted Time:
2023-05-02 14:04:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
105770 West Pharmaceutical Services Inc WST Surgical & Medical Instruments & Apparatus (3841) 231210010
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1733001 Silji Abraham 530 Herman O. West Drive
Exton 19341
Svp, Chief Technology Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-01 8,020 $86.24 12,229 No 4 M Direct
Common Stock Disposition 2023-05-01 7,371 $365.55 4,858 No 4 S Direct
Common Stock Disposition 2023-05-01 649 $366.14 4,209 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2023-05-01 8,020 $0.00 8,020 $86.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-02-26 2028-02-26 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $365.00 to $365.91, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
  2. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $366.0350 to $366.18, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
  3. This award vests in 4 equal annual installments beginning on 2/26/2019.